CVT Cases Turn up in Patients Vaccinated with mRNA-based Vaccine: a Black Swan or Predictable Event?

CVT Cases Turn up in Patients Vaccinated with mRNA-based Vaccine: a Black Swan or Predictable Event?

The COVID-19 vaccines are necessary and key to overcoming this pandemic. TrialSite, a data- and science-driven platform, reports continually on the correlation of reduced hospitalization and death in association with the COVID-19 vaccines. Yet it’s that same science that compels ongoing queries into questions, challenges, and anomalies that need addressing. Recently, another data point surfaced that TrialSite shares with the rapidly growing global community interested in transparent and accessible research for the betterment of healthcare worldwide. A group of prominent researchers from Singapore published the results of a case series in the form of a correspondence report in the American Journal of Hematology titled, “Cerebral Venous Thrombosis Post BNT162b2 mRNA SARS-CoV-2 Vaccination: A Black Swan Event.” The authors report on three patients afflicted with incredibly rare CVT associated with the mRNA-based Pfizer-BioNTech vaccine known as BNT162b2. The incidence of CVT in this case series, although just one report and a few patients, should nonetheless be taken seriously by regulators. As should TrialSite’s recent argument that the vaccine’s dosage should be cut back. This coul...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee